From Medscape Oncology

Medscape Medical News from the:

American Society of Hematology (ASH) 53rd Annual Meeting

December 10 - 13, 2011; San Diego, California

This coverage is not sanctioned by, nor a part of, the American Society of Hematology.

Meeting Highlights at a Glance

Top News From ASH 2011: Slideshow
Highlights include using chemotherapy alone for limited-stage Hodgkin's disease, and less is more for rituximab in low-burden follicular lymphoma.

Conference News

Medscape Oncology©  WebMD, LLC

Medscape Oncology Insights

Has Rituximab Met Its Match in Lymphoma?
Bruce D. Cheson, MD
John P. Leonard, MD

Radioimmunotherapy: Moving Up Front?
Bruce D. Cheson, MD

Gemtuzumab Boosts Survival in AML
Richard M. Stone, MD

Multiple New Drugs for Multiple Myeloma
Paul G. Richardson, MD

Two New Winners for CML?
Jorge E. Cortes, MD

A Dickensian CLL Story
Bruce D. Cheson, MD; Clemens Wendtner, MD

Pre-Meeting Expert Commentary

ASH Preview: A Look at What’s Hot
Bruce D. Cheson, MD